Donald M. Gleason - Concepedia

Author

Donald M. Gleason

Also Known As

D GLEASON, D M Gleason, D. Gleason, D. M. Gleason, D.M. Gleason, DONALD GLEASON, DONALD M. GLEASON, Donald Gleason, Donald M. Gleason

Publications

5.2K

Citations

H-Index

Concepts

All Affiliations

University of Arizona Tucson Medical Center Columbia University Urology Associates NewYork–Presbyterian Hospital

About

Donald M. Gleason is an author at University of Arizona specializing in medicine, urology, and urogynecology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	32	1.7K
2	Health Sciences	6	6	188
3	Engineering	2	2	35
4	Public Health	1	1	22
5	Social Sciences	1	1	33

Donald M. Gleason

Publications

4.8K

Citations

H-Index

Page 1

	Year	Citations
A Randomized, Placebo-Controlled Trial of Zoledronic Acid in Patients With Hormone-Refractory Metastatic Prostate Carcinoma Fred Saad, Donald M. Gleason, Robin Murray, JNCI Journal of the National Cancer Institute	2002	1.7K
Randomized Controlled Trial of Zoledronic Acid to Prevent Bone Loss in Men Receiving Androgen Deprivation Therapy for Nonmetastatic Prostate Cancer Matthew R. Smith, James A. Eastham, Donald M. Gleason, The Journal of Urology	2003	644
Standardization of terminology of lower urinary tract function: Pressure-flow studies of voiding, urethral resistance, and urethral obstruction Derek Griffiths, K. Höfner, R. van Mastrigt, Neurourology and Urodynamics	1997	456
Clinical Efficacy and Safety of Tolterodine Compared to Oxybutynin and Placebo in Patients with Overactive Bladder Harold P. Drutz, Rodney A. Appell, Donald M. Gleason, International Urogynecology Journal Urological ResearchUrologyVoiding DysfunctionMedicineTolterodine Compared	1999	234
Bicalutamide as Immediate Therapy Either Alone or as Adjuvant to Standard Care of Patients with Localized or Locally Advanced Prostate Cancer: First Analysis of the Early Prostate Cancer Program William A. See, Manfred P. Wirth, David G. McLeod, The Journal of Urology	2002	229
A new injectable bulking agent for treatment of stress urinary incontinence: results of a multicenter, randomized, controlled, double-blind study of Durasphere Deborah J. Lightner, Carlos Calvosa, Roger C. Andersen, Urology UrologyVoiding DysfunctionStress Urinary IncontinencePelvic Reconstructive SurgeryDouble-blind Study	2001	195
A phase 3, multicenter, open-label, randomized study of abarelix versus leuprolide acetate in men with prostate cancer David G. McLeod, Norman R. Zinner, Kevin M. Tomera, Urology UrologyGenitourinary CancerRandomized StudyMedicinePharmacology	2001	164
The Urethral Continence Zone and its Relation to Stress Incontinence Donald M. Gleason, Robert J. Reilly, Manfred R. Bottaccini, The Journal of Urology Urological ResearchUrologyVoiding DysfunctionUrethral Continence ZonePelvic Floor Disorders	1974	122
Evaluation of a new once-daily formulation of oxybutynin for the treatment of urinary urge incontinence Donald M. Gleason, Jacques G. Susset, C Michael White, Urology Urinary Urge IncontinenceUrologyVoiding DysfunctionPelvic ProlapseFemale Urology	1999	119
THE GONADOTROPIN-RELEASING HORMONE ANTAGONIST ABARELIX DEPOT VERSUS LUTEINIZING HORMONE RELEASING HORMONE AGONISTS LEUPROLIDE OR GOSERELIN: INITIAL RESULTS OF ENDOCRINOLOGICAL AND BIOCHEMICAL EFFICACIES IN PATIENTS WITH PROSTATE CANCER Kevin M. Tomera, Donald M. Gleason, Marc Gittelman, The Journal of Urology UrologyOncologyMedicineHormonal ReceptorPharmacotherapy	2001	99

Page 1